News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,849 Results
Type
Article (18317)
Company Profile (115)
Press Release (363417)
Multimedia
Podcasts (19)
Webinars (6)
Section
Business (121044)
Career Advice (789)
Deals (27712)
Drug Delivery (34)
Drug Development (43429)
Employer Resources (61)
FDA (7864)
Job Trends (8547)
News (200435)
Policy (14937)
Tag
Academia (958)
Accelerated approval (3)
Adcomms (12)
Allergies (23)
Alliances (27905)
ALS (40)
Alzheimer's disease (470)
Antibody-drug conjugate (ADC) (124)
Approvals (7928)
Artificial intelligence (174)
Autoimmune disease (12)
Automation (6)
Bankruptcy (191)
Best Places to Work (6835)
BIOSECURE Act (4)
Biosimilars (48)
Biotechnology (99)
Bladder cancer (67)
Brain cancer (25)
Breast cancer (240)
Cancer (1916)
Cardiovascular disease (68)
Career advice (674)
Career pathing (11)
CAR-T (108)
Cell therapy (278)
Cervical cancer (16)
Clinical research (36223)
Collaboration (564)
Company closure (2)
Compensation (261)
Complete response letters (6)
COVID-19 (890)
CRISPR (23)
C-suite (184)
Cystic fibrosis (32)
Data (1394)
Decentralized trials (1)
Depression (19)
Diabetes (110)
Diagnostics (3625)
Digital health (12)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (81)
Drug pricing (28)
Drug shortages (4)
Duchenne muscular dystrophy (33)
Earnings (52676)
Editorial (16)
Employer branding (11)
Employer resources (59)
Events (60416)
Executive appointments (515)
FDA (8624)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (421)
Gene editing (50)
Generative AI (13)
Gene therapy (134)
GLP-1 (355)
Government (1388)
Guidances (111)
Healthcare (10134)
Huntington's disease (2)
IgA nephropathy (15)
Immunology and inflammation (63)
Indications (18)
Infectious disease (943)
Inflammatory bowel disease (69)
Inflation Reduction Act (4)
Influenza (19)
Intellectual property (62)
Interviews (114)
IPO (10814)
IRA (16)
Job creations (2017)
Job search strategy (591)
Kidney cancer (11)
Labor market (9)
Layoffs (282)
Leadership (8)
Legal (3785)
Liver cancer (59)
Lung cancer (286)
Lymphoma (112)
Machine learning (3)
Management (19)
Manufacturing (166)
MASH (39)
Medical device (6326)
Medtech (6327)
Mergers & acquisitions (17394)
Metabolic disorders (289)
Multiple sclerosis (36)
NASH (8)
Neurodegenerative disease (29)
Neuropsychiatric disorders (8)
Neuroscience (731)
NextGen: Class of 2025 (3275)
Non-profit (1749)
Now hiring (10)
Obesity (145)
Opinion (117)
Ovarian cancer (67)
Pain (38)
Pancreatic cancer (62)
Parkinson's disease (69)
Partnered (10)
Patents (111)
Patient recruitment (63)
Peanut (12)
People (36112)
Pharmaceutical (28)
Pharmacy benefit managers (6)
Phase I (11861)
Phase II (15504)
Phase III (12299)
Pipeline (1008)
Policy (44)
Postmarket research (1266)
Preclinical (4331)
Press Release (68)
Prostate cancer (85)
Psychedelics (6)
Radiopharmaceuticals (195)
Rare diseases (184)
Real estate (3018)
Recruiting (20)
Regulatory (10840)
Reports (24)
Research institute (1180)
Resumes & cover letters (124)
Rett syndrome (5)
RSV (15)
Schizophrenia (53)
Series A (79)
Series B (47)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (67)
Sponsored (12)
Startups (2056)
State (2)
Stomach cancer (10)
Supply chain (27)
Tariffs (13)
The Weekly (19)
Vaccines (263)
Venture capitalists (22)
Weight loss (97)
Women's health (4)
Worklife (2)
Date
Last 7 days (587)
Last 30 days (1798)
Last 365 days (19827)
2025 (7337)
2024 (21381)
2023 (24147)
2022 (32535)
2021 (33968)
2020 (31052)
2019 (24646)
2018 (19097)
2017 (18740)
2016 (17200)
2015 (20752)
2014 (15632)
2013 (12423)
2012 (13264)
2011 (13829)
2010 (13220)
Location
Africa (361)
Alabama (28)
Alaska (4)
Arizona (98)
Arkansas (5)
Asia (23156)
Australia (3303)
California (3781)
Canada (1258)
China (357)
Colorado (145)
Connecticut (181)
Delaware (134)
Europe (49519)
Florida (560)
Georgia (71)
Idaho (32)
Illinois (305)
India (15)
Indiana (153)
Iowa (4)
Japan (140)
Kansas (36)
Kentucky (15)
Louisiana (7)
Maine (49)
Maryland (461)
Massachusetts (2883)
Michigan (125)
Minnesota (202)
Mississippi (1)
Missouri (39)
Montana (20)
Nebraska (15)
Nevada (38)
New Hampshire (30)
New Jersey (1135)
New Mexico (14)
New York (1018)
North Carolina (587)
North Dakota (5)
Northern California (1756)
Ohio (123)
Oklahoma (6)
Oregon (11)
Pennsylvania (738)
Puerto Rico (5)
Rhode Island (19)
South America (551)
South Carolina (12)
Southern California (1374)
Tennessee (78)
Texas (506)
United States (13806)
Utah (111)
Virginia (84)
Washington D.C. (30)
Washington State (321)
West Virginia (2)
Wisconsin (38)
381,849 Results for "abraxis oncology acquired by celgene corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider
April 30, 2025
·
2 min read
Press Releases
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
March 5, 2025
·
14 min read
Press Releases
Predictive Oncology Announces Agreement to be Acquired by Renovaro
January 6, 2025
·
6 min read
Legal
Celgene Shareholders Hit BMS with Fresh Lawsuit for Allegedly Dodging CVR Payments
BMS has so far been on a winning streak in the contingent value right cases, which allege that the pharma intentionally delayed regulatory activities for Breyanzi in order to avoid a $6.4 billion payout to Celgene shareholders.
November 15, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
January 9, 2025
·
6 min read
Press Releases
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 6, 2025
·
5 min read
Press Releases
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 8, 2025
·
11 min read
Press Releases
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
·
4 min read
Press Releases
BioNTech to Acquire Biotheus to Boost Oncology Strategy
November 14, 2024
·
11 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
November 25, 2024
·
7 min read
1 of 38,185
Next
